TNDM Q1 2022 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$176M+24.7% YoY

Gross Profit

$91M51.8% margin

Operating Income

-$15M-8.7% margin

Net Income

-$15M-8.4% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-16.2%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$11M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$578M

Stockholders' Equity

$437M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$176M	$141M	+24.7%
Gross Profit	$91M	$73M	+24.3%
Operating Income	-$15M	-$3M	-373.8%
Net Income	-$15M	-$5M	-191.7%

Geographic Segments

UNITED STATES

$131M75%

Non-US

$45M25%